Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"5S371K6132"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Hou%2C+Zhiguo%22&type=Person&filter%5B%5D=topic_facet%3A%225S371K6132%22
/vufind/Search/Results?lookfor=%22Hou%2C+Zhiguo%22&type=Person&filter%5B%5D=topic_facet%3A%225S371K6132%22
Search /vufind/Search2/Results?lookfor=%22Hou%2C+Zhiguo%22&type=Person&filter%5B%5D=topic_facet%3A%225S371K6132%22
PubPharm (7)
1
First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE) : a phase 1 study
enthalten in:
Signal transduction and targeted therapy
| 2024
von
Chen, X.
|
Xu, H.
|
Chen, X.
| +25
Wird geladen...
2
Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC : a drug-drug interaction study
enthalten in:
Cancer chemotherapy and pharmacology
| 2023
von
Ma, Y.
|
Chen, Q.
|
Zhang, Y.
| +11
Wird geladen...
3
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD) : a prospective, single-arm, multicenter, phase IV study
enthalten in:
BMC medicine
| 2023
von
Li, J.
|
Qin, S.
|
Wen, L.
| +32
Wird geladen...
4
Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer : The APPROVE Randomized Clinical Trial
enthalten in:
JAMA oncology
| 2022
von
Wang, T.
|
Tang, J.
|
Yang, H.
| +14
Wird geladen...
5
Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02) : a single-arm, open-label, phase 2 trial
enthalten in:
The lancet. Gastroenterology & hepatology
| 2022
von
Meng, X.
|
Wu, T.
|
Hong, Y.
| +21
CommentIn: Lancet Gastroenterol Hepatol. 2022 Mar;7(3):200-201. - PMID 34998470
Wird geladen...
6
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer : The REALITY Randomized Clinical Trial
enthalten in:
JAMA oncology
| 2022
von
Lin, Y.
|
Qin, S.
|
Li, Z.
| +22
CommentIn: JAMA Oncol. 2022 Feb 1;8(2):250-251. - PMID 34913944
Wird geladen...
7
Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC : The Phase III ACTIVE Study (CTONG1706)
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2021
von
Zhao, H.
|
Yao, W.
|
Min, X.
| +23
CommentIn: J Thorac Oncol. 2021 Sep;16(9):1426-1428. - PMID 34425993
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: 5S371K6132
Medienart
7
Aufsätze
7
E-Artikel
7
E-Ressourcen
Zeitschriftentitel
2
JAMA oncology
1
BMC medicine
1
Cancer chemotherapy and pharmacology
1
Journal of thoracic oncology : official publica...
1
Signal transduction and targeted therapy
1
The lancet. Gastroenterology & hepatology
Alle anzeigen ...
weniger ...
Thema
5S371K6132
7
Journal Article
7
apatinib
6
Research Support, Non-U.S. Gov't
5
Pyridines
3
Apatinib
3
EC 2.7.10.1
3
Randomized Controlled Trial
2
73096E137E
2
Antibodies, Monoclonal, Humanized
2
Antineoplastic Agents
2
EGFR protein, human
2
ErbB Receptors
2
Gefitinib
2
Multicenter Study
2
Protein Kinase Inhibitors
2
S65743JHBS
2
Vascular Endothelial Growth Factor A
2
camrelizumab
1
04ZR38536J
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
2
2023
3
2022
1
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7
Englisch
Haven't found what you're looking for?
Wird geladen...